XML 34 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings per Share
9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
The Company has unvested shares of restricted stock and restricted stock units outstanding that are considered participating securities and, therefore, computes basic and diluted earnings per share under the two-class method. Basic earnings per share for the periods are based upon the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share include the effect of certain stock options.
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2016
 
2015
 
2016
 
2015
Net income attributable to
   Westlake Chemical Corporation
 
$
65,662

 
$
183,604

 
$
299,914

 
$
535,041

Less:
 
 
 
 
 
 
 
 
Net income attributable to participating securities
 
(294
)
 
(195
)
 
(1,347
)
 
(653
)
Net income attributable to common shareholders
 
$
65,368

 
$
183,409

 
$
298,567

 
$
534,388


The following table reconciles the denominator for the basic and diluted earnings per share computations shown in the consolidated statements of operations:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2016
 
2015
 
2016
 
2015
Weighted average common shares—basic
 
128,793,661

 
131,664,296

 
129,519,577

 
132,301,814

Plus incremental shares from:
 
 
 
 
 
 
 
 
Assumed exercise of options
 
586,295

 
456,939

 
584,320

 
484,720

Weighted average common shares—diluted
 
129,379,956

 
132,121,235

 
130,103,897

 
132,786,534

 
 
 
 
 
 
 
 
 
Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
 
 
Basic
 
$
0.51

 
$
1.39

 
$
2.31

 
$
4.04

Diluted
 
$
0.51

 
$
1.39

 
$
2.29

 
$
4.02


Excluded from the computation of diluted earnings per share are options to purchase 620,010 and 315,285 shares of common stock for the three months ended September 30, 2016 and 2015, respectively, and 577,254 and 295,825 shares of common stock for the nine months ended September 30, 2016 and 2015, respectively. These options were outstanding during the periods reported but were excluded because the effect of including them would have been antidilutive.